Financhill
Buy
65

TRV Quote, Financials, Valuation and Earnings

Last price:
$260.62
Seasonality move :
3.5%
Day range:
$260.09 - $266.74
52-week range:
$200.21 - $269.56
Dividend yield:
1.58%
P/E ratio:
12.35x
P/S ratio:
1.32x
P/B ratio:
2.16x
Volume:
1.8M
Avg. volume:
1.3M
1-year change:
20.01%
Market cap:
$60.1B
Revenue:
$46.4B
EPS (TTM):
$21.47

Earnings Data

Next earnings date for TRV
Apr 17
2025
Most recent earnings per share
$8.96
Beat by $2.36
(Jan 22/2025)
Consensus Estimate
$6.60
(Jan 22/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

TRV Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
04/17/2025 Q1 $11B -- -- $1.28 --
01/22/2025 Q4 $10.8B $12B $8.96 $6.60 $2.36
10/17/2024 Q3 $10.6B $11.9B $5.42 $3.59 $1.83
07/19/2024 Q2 $10.4B $11.3B $2.29 $2.00 $0.29
04/17/2024 Q1 $10.2B $11.2B $4.80 $4.86 -$0.06
01/19/2024 Q4 $9.9B $10.9B $6.99 $5.09 $1.90
10/18/2023 Q3 -- -- $1.74 $3.07 -$1.33
07/20/2023 Q2 -- -- -$0.07 $2.12 -$2.19
04/19/2023 Q1 -- -- $4.13 $3.58 $0.55
01/24/2023 Q4 -- -- $3.44 $3.40 $0.04
10/19/2022 Q3 -- -- $1.89 $1.60 $0.29
07/21/2022 Q2 -- -- $2.27 $1.97 $0.30
04/19/2022 Q1 -- -- $4.15 $3.62 $0.53
01/20/2022 Q4 -- -- $5.37 $3.81 $1.56
10/19/2021 Q3 -- -- $2.62 $1.93 $0.69
07/20/2021 Q2 -- -- $3.66 $2.38 $1.28
04/20/2021 Q1 -- -- $2.87 $2.40 $0.47
01/21/2021 Q4 -- -- $5.10 $3.15 $1.95
10/20/2020 Q3 -- -- $3.23 $3.04 $0.19
07/23/2020 Q2 -- -- -$0.16 -$0.20 $0.04
04/21/2020 Q1 -- -- $2.33 $2.86 -$0.53
01/23/2020 Q4 -- -- $3.35 $3.27 $0.08
10/22/2019 Q3 -- -- $1.50 $2.35 -$0.85
07/23/2019 Q2 -- -- $2.10 $2.30 -$0.20
04/18/2019 Q1 -- -- $2.99 $2.73 $0.26
01/22/2019 Q4 -- -- $2.13 $2.18 -$0.05
10/18/2018 Q3 -- -- $2.62 $2.26 $0.36
07/19/2018 Q2 -- -- $1.92 -- --
04/24/2018 Q1 -- -- $2.42 -- --
01/23/2018 Q4 -- -- $1.98 -- --
10/19/2017 Q3 -- -- $1.05 -- --
07/20/2017 Q2 -- -- $2.11 -- --
04/20/2017 Q1 -- -- $2.17 -- --
01/24/2017 Q4 -- -- $3.28 -- --
10/20/2016 Q3 -- -- $2.45 -- --
07/21/2016 Q2 -- -- $2.24 -- --
04/21/2016 Q1 -- -- $2.30 -- --
01/21/2016 Q4 -- -- $2.83 -- --
10/20/2015 Q3 -- -- $2.97 -- --
07/21/2015 Q2 -- -- $2.53 -- --
04/21/2015 Q1 -- -- $2.55 -- --

The Travelers Companies Earnings Questions

  • How Much did The Travelers Companies Generate in Revenue Last Quarter?

    The Travelers Companies reported $12B worth of top line sales in its most recent quarter.

  • Did The Travelers Companies Beat Earnings Last Quarter?

    The Travelers Companies announced earnings per share of $8.96 which represents a beat of analyst forecast a $6.60 per share.

  • Is The Travelers Companies Profitable?

    The Travelers Companies reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for The Travelers Companies EPS Next Year?

    The Travelers Companies's earnings are forecast to decrease from $21.47 per share to $18.94 per share next year representing a decrease of -15.64%.

  • When is The Travelers Companies's Earnings Date?

    The Travelers Companies's next earnings date is April 17, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Pepsi Vs Coke Stock: Which Is Best?
Pepsi Vs Coke Stock: Which Is Best?

Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 19

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 19

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock